CTDD vs OGN · rev $5.51B vs P/E 3.4, rev $6.40B
Qwest Corp 6 75 Notes Expiry 2057 (CTDD) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Qwest Corp 6 75 Notes Expiry 2057 (CTDD) common stock listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CTDD revenue for 2024-12-31 was $5.51B. Revenue was down 6.9% from 2023-12-31 to 2024-12-31. CTDD currently screens at market cap $0.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CTDD currently screens at market cap $0. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CTDD and OGN stock pages for the full models.
Not investment advice.